325 related articles for article (PubMed ID: 9229372)
1. Epilepsy and antiphospholipid antibodies in systemic lupus erythematosus patients.
Formiga F; Mitjavila F; Pac M; Moga I
Lupus; 1997; 6(5):486. PubMed ID: 9229372
[No Abstract] [Full Text] [Related]
2. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
Viveros ME; Cabiedes J; Reyes E; Cabral AR
Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of anticardiolipin antibodies and epilepsy in lupus patients.
Liou HH; Wang CR; Chen CJ; Chen RC; Chuang CY; Chiang IP; Tsai MC
Lupus; 1996 Aug; 5(4):307-12. PubMed ID: 8869904
[TBL] [Abstract][Full Text] [Related]
4. Association between IgM anticardiolipin antibodies and deep venous thrombosis in patients without systemic lupus erythematosus.
Oger E; Lernyer C; Dueymes M; Le Moigne E; Bressolette L; Escoffre M; Youinou P; Mottier D
Lupus; 1997; 6(5):455-61. PubMed ID: 9229365
[TBL] [Abstract][Full Text] [Related]
5. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysis.
Wahl DG; Guillemin F; de Maistre E; Perret C; Lecompte T; Thibaut G
Lupus; 1997; 6(5):467-73. PubMed ID: 9229367
[TBL] [Abstract][Full Text] [Related]
6. MHC gene products and anticardiolipin antibodies in systemic lupus erythematosus results of a multicenter study. SLE Study Group.
Hartung K; Coldewey R; Corvetta A; Deicher H; Kalden JR; Krapf F; Lang B; Lakomek HJ; Liedvogel B; Peter HH
Autoimmunity; 1992; 13(2):95-9. PubMed ID: 1467439
[TBL] [Abstract][Full Text] [Related]
7. Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Alessandri C; Bombardieri M; Di Prospero L; Conigliaro P; Conti F; Labbadia G; Misasi R; Sorice M; Valesini G
Clin Exp Immunol; 2005 Apr; 140(1):173-80. PubMed ID: 15762889
[TBL] [Abstract][Full Text] [Related]
8. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus.
Herranz MT; Rivier G; Khamashta MA; Blaser KU; Hughes GR
Arthritis Rheum; 1994 Apr; 37(4):568-71. PubMed ID: 8147935
[TBL] [Abstract][Full Text] [Related]
9. Differences in protein S and C4b-binding protein levels in different groups of patients with antiphospholipid antibodies.
Forastiero RR; Kordich L; Basilotta E; Carreras LO
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):609-16. PubMed ID: 7841319
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous coronary artery dissection in the context of positive anticardiolipin antibodies and clinically undiagnosed systemic lupus erythematosus.
Nisar MK; Mya T
Lupus; 2011 Nov; 20(13):1436-8. PubMed ID: 21768175
[TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus.
Campos LM; Kiss MH; D'Amico EA; Silva CA
Lupus; 2003; 12(11):820-6. PubMed ID: 14667097
[TBL] [Abstract][Full Text] [Related]
12. Lupus and cerebrovascular accidents.
Ware AE; Mongey AB
Lupus; 1997; 6(5):420-4. PubMed ID: 9229359
[No Abstract] [Full Text] [Related]
13. [Antiphospholipid syndrome in SLE males].
Nasonov EL; Alekberova ES; Kliukvina NG; Aleksandrova EN; Salozhin KV; Le Tonqueze M; Youinou P
Klin Med (Mosk); 1996; 74(4):18-22. PubMed ID: 8999143
[No Abstract] [Full Text] [Related]
14. Serum apolipoprotein H levels in systemic lupus erythematosus are not influenced by antiphospholipid antibodies.
Ichikawa Y; Takamatsu K; Shimizu H; Uchiyama M; Moriuchi J; Takaya M; Kobayashi N; Kawada T; Arimori S
Lupus; 1992 May; 1(3):145-9. PubMed ID: 1301975
[TBL] [Abstract][Full Text] [Related]
15. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.
Neville C; Rauch J; Kassis J; Chang ER; Joseph L; Le Comte M; Fortin PR
Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633
[TBL] [Abstract][Full Text] [Related]
16. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome].
Soltész P; Veres K; Kiss E; Lakos G; Sonkoly I; Muszbek L; Szegedi G
Orv Hetil; 2000 Dec; 141(52):2821-5. PubMed ID: 11202118
[TBL] [Abstract][Full Text] [Related]
17. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
18. IgM anti-β2 glycoprotein I is protective against lupus nephritis and renal damage in systemic lupus erythematosus.
Mehrani T; Petri M
J Rheumatol; 2011 Mar; 38(3):450-3. PubMed ID: 21123325
[TBL] [Abstract][Full Text] [Related]
19. Which antiphospholipid antibodies should be measured in the antiphospholipid syndrome?
Galli M
Haemostasis; 2000; 30 Suppl 2():57-62. PubMed ID: 11251342
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid antibodies, haemostatic variables and thrombosis--a survey of 144 patients.
Ames PR; Pyke S; Iannaccone L; Brancaccio V
Thromb Haemost; 1995 May; 73(5):768-73. PubMed ID: 7482401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
